Towards Healthcare
Antacids Market Size Envisions USD 10.33 Billion by 2034

Antacids Market Size, Key Players, Emerging Trends and Strategic Insights

Projections indicate that, antacids industry is projected to rise from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, reflecting a CAGR of 3.30% over the next decade. The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely used OTC, antacids neutralize stomach acid, offering quick relief for GERD, heartburn, and ulcers, driving global market demand.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antacids Market Assessment

  • Overview
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Antacids Market Assessment

  • Overview
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Europe Antacids Market Assessment

  • Overview
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Asia-Pacific Antacids Market Assessment

  • Overview
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Latin America Antacids Market Assessment

  • Overview
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Middle East and Africa Antacids Market Assessment

  • Overview
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Company Profiles

  • Bayer AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GlaxoSmithKline Plc.
  • Takeda Pharmaceutical Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr Reddy's Laboratories Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc.
  • Cipla Ltd.
  • Alkem Laboratories Ltd.
  • Abbott Laboratories

Conclusion & Recommendations

  • Insight Code: 5079
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The rise is attributed to factors like dietary habits and lifestyle changes. Consequently, the antacid market has grown is due prevalence of diseases to meet the increasing demand for treating the symptoms of acid reflux. The Aging Population is also responsible for Driving Demand for Antacids.

The major key players operating in the antacid market are Bayer AG, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Pfizer Inc., Reckitt Benckiser Group Plc., Cipla Ltd., Alkem Laboratories Ltd., and Abbott Laboratories.

North America and Asia-Pacific are the leading region for the Global Antacid Market.

National Institute of Health, World Health Organisation, Centers for Disease Control and Prevention, American Journal of Health-System Pharmacy, USDA | Economical Research Services, ScienceDirect, Wolters Kluwer, MedlinePlus(.gov), International Journal of Research in Medical Sciences